India's Lupin joins stampede into injectable meds with Nanomi buyout

India's Lupin is staking a claim in sterile injectables, with a deal to buy the Netherlands-based drugmaker Nanomi. The market for injectable meds, which are complicated to develop and manufacture, has been heating up, and Lupin's buy is the third in the space in recent weeks. Report